Copyright: ©Author(s) 2026.
World J Cardiol. May 26, 2026; 18(5): 120519
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.120519
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.120519
Figure 1 Sphingosine-1-phosphate receptor 1 expression in different groups.
A: Sphingosine-1-phosphate receptor 1 expression in control group (71 cases) and coronary atherosclerotic heart disease group (40 cases); B: Sphingosine-1-phosphate receptor 1 expression in low Gensini score group (48 cases) and high Gensini score group (23 cases). aP < 0.001 vs control, bP < 0.01 vs low score. S1PR1: Sphingosine-1-phosphate receptor 1; CAHD: Coronary atherosclerotic heart disease.
- Citation: Chu FY, Yao MH, Gu LM, Cai H, Li YN, Chen X, Xu XX. S1PR1 knockdown protects endothelial cells from oxidized low-density lipoprotein-induced injury via reducing interleukin-1β and tumor necrosis factor-α expression. World J Cardiol 2026; 18(5): 120519
- URL: https://www.wjgnet.com/1949-8462/full/v18/i5/120519.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i5.120519